Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-27T01:07:40.023Z Has data issue: false hasContentIssue false
  • English
  • Français

IX.—Clinical Uses of Albumin

Published online by Cambridge University Press:  05 December 2011

Alex. M. Davison
Alex. M. Davison
Affiliation:
Research Fellow, Department of Pathology, University of Edinburghand Medical Renal Unit, Department of Medicine, Edinburgh Royal Infirmary
Get access

Extract

Plasma fractionation has provided a number of materials which may be used to treat conditions in which whole blood would be of little or no value. It was in 1944 that Cohn and his co-workers published a series of papers on plasma fractionation (Cohn et al. 1944) and in the same year Janeway and his colleagues first suggested the use of albumin in hypoproteinaemic states (Janeway et al. 1944). Since then many accounts of the treatment of generalised oedema have mentioned the employment of salt-poor albumin as an adjunct to therapy (Chamberlain et al. 1966; Garnet and Webber 1967; Silverberg and Kjellstrand 1968; Snashall 1971), but no attempt has been made recently to evaluate the place of albumin in such patients.

Type
Research Article
Information
Proceedings of the Royal Society of Edinburgh, Section B: Biological Sciences , Volume 71 , supplement S1 , 1972 , pp. s83 - s87
Copyright
Copyright © Royal Society of Edinburgh 1972

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References to Literature

Allison, M. E. M. and Kennedy, A. C., 1971. Diuretics in chronic renal disease: a study of high dose frusemide. Clin. Sci., 41, 171–187.CrossRefGoogle Scholar
Chamberlain, M. J., Pringle, A. and Wrong, O. M., 1966. Oliguric renal failure in the nephrotic syndrome. Q. J Med., 35, 215–235.Google ScholarPubMed
Cohn, E. J., Oncley, J. L., Strong, L. E., Hughes, W. L. Jnr. and Armstrong, S. H. Jnr., 1944. Chemical clinical and immunological studies on the products of human plasma fractionation. I. The characterization of the protein fractions of human plasma. J. Clin. Invest., 23, 417.CrossRefGoogle ScholarPubMed
Garnett, E. S. and Webber, C. E., 1967. Changes in blood volume produced by treatment in the nephrotic syndrome. Lancet, 2, 798–799.CrossRefGoogle ScholarPubMed
Janeway, C. A., Gibson, S. T., Woodruff, L. M., Heyl, J. T., Bailey, O. T. and Newhouser, L. R., 1944. Chemical, clinical and immunological studies on the products of human plasma fractionation. VII. Concentrated human serum albumin. J. Clin. Invest., 23, 465–490.CrossRefGoogle ScholarPubMed
Luetscher, J. A. Jnr., Hall, A. D. and Kremer, V. L. 1949. Treatment of nephrosis with concentrated human serum albumin. I. Effects on the proteins of body fluids. J. Clin. Invest., 28, 700–712.CrossRefGoogle ScholarPubMed
Muth, R. C., 1968. Diuretic properties of furosemide in renal disease. Ann. Intern. Med., 69, 249–261.CrossRefGoogle ScholarPubMed
Nicolaysen, G., 1971. Intravascular concentration of calcium and magnesium ions and oedema formation in isolated lungs. Acta Physiol. Scand., 81, 325–339.CrossRefGoogle ScholarPubMed
Silverberg, D. S. and Kjellstrand, C. M., 1968. Clinical use of high doses of furosemide (Lasix) in the treatment of resistant nephrotic edema. Acta. Med. Scand., 184, 473–479.CrossRefGoogle ScholarPubMed
Snashall, P. D., 1971. Gross oedema in the nephrotic syndrome treated with frusemide in high dosage. Br. Med. J., 2, 319–321.CrossRefGoogle Scholar
Walker, W. A., Ulstrom, R. A. and Lowman, J. T., 1971. Albumin synthesis rates in patients with hypoproteinaemia. J. Pediat., 78, 812–820.CrossRefGoogle Scholar
Weiner, M. W., Weinman, E. J., Kashgarian, M. and Hayslett, J. P., 1971. Accelerated reabsorption in the proximal tubule produced by volume depletion. J. Clin. Invest., 50, 1379–1385.CrossRefGoogle ScholarPubMed